PuraPharm Corporation Limited (1498.HK) HKSE
0.33
+0(+0.00%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.33
+0(+0.00%)
Currency In HKD
| Market Cap | 217.28M |
| Enterprise Value | 568.25M |
| P/E Ratio | -3.33 |
| PEG Ratio | 0.38 |
| Price/Sales Ratio | 0.37 |
| Price/Book Ratio | 1.26 |
| Enterprise/Revenue | 1.4 |
| Enterprise/EBITDA | 46.53 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | June 30, 2025 |
| Profit Margin | -0.11 |
| Operating Margin | -0.13 |
| Return On Assets | -0.06 |
| Return On Equity | -0.36 |
| Revenue | 382.09M |
| Revenue/Share | 0.88 |
| Gross Profit | 205.14M |
| EBITDA | 17.35M |
| Net Income | -35.44M |
| Diluted EPS | -0.09 |
| Total Cash | 49.89M |
| Total Cash/Share | 0.13 |
| Total Debt | 374.45M |
| Total Debt/Equity | 3.68 |
| Current Ratio | 0.52 |
| Book Value Per Share | 0.26 |
| 52-Week Change | -41.96 |
| 52-Week High | 0.65 |
| 52-Week Low | 0.3 |
| Moving Average 50 Days | 0.34 |
| Moving Average 200 Days | 0.41 |
| Average Volume | 303,830 |
| Shares Outstanding | 394.94M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 18:17 |
| Last Split Date | January 29, 2020 |